Bud BilanichSuccess Coach
Matt TurnerPatient Affordability
Brenda SnowAuthentic Patient Voice
Joey CohenMedication Adherence
David LinetskyPoint-of-Care Marketing
Matthew DurhamOmnidynamic Marketing
Pat PurcellMeeting Engagement
Paul TheisenPatient Acquisition
Suma Ramadas, PhDMedical Affairs
Liz KaneImpactful Strategy
Daniel SontupeMarket Access
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
CHICAGO, Aug. 01, 2017 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider ...
Phase 1/2 clinical trial combines Regeneron’s PD-1 inhibitor cemiplimab and Inovio’s immunotherapy INO-5401 in ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email